IONTAS and FairJourney Biologics enter antibody discovery agreement with Quell Therapeutics
Diverse panel of novel target binders from IONTAS / FJB will be used to uncover functional antibodies to advance Quell’s engineered Treg cell therapy pipeline Cambridge, UK, Porto, Portugal, and London, UK – 08 March 2021: IONTAS Limited (IONTAS) and FairJourney...
Case studies
The expertise, capacity and skills of FairJourney Biologics team is illustrated in several case studies that can be consulted here
Libraries
Libraries performed at FairJourney Biologics
